Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mark Hurd’s Legacy Lives On at Hewlett-Packard Company (HPQ)

When Hewlett-Packard Company (NYSE:HPQ) parted ways with former CEO Mark Hurd, the scandal-tinged affair left a bad taste in many an investor’s mouth. The company and its shareholders took a broom to the boardroom, sweeping out many of the people responsible for Hewlett-Packard Company (NYSE:HPQ)’s strategy in the Hurd era. Only two of HP’s directors from that time still serve on the board.

Hewlett-Packard Company (NYSE:HPQ)

One year later, Hewlett-Packard Company (NYSE:HPQ) unceremoniously dumped another chief executive who dared to try a bold new strategy — built on feet of financial clay. Leo Apotheker wanted to take HP in a strongly software-based direction, acquiring British data-management specialist Autonomy in a blockbuster $11 billion deal. The people who hired and fired him, not to mention allowed Apotheker to strike that unfortunate deal, still make up the majority of Hewlett-Packard Company (NYSE:HPQ)’s board. An $8.8 billion writedown of the $11 billion acquisition wasn’t enough to bring in another cleaning squad.

So-called “queen of corporate governance” Nell Minow used HP as a prime example of bad governance, and Foolish star analyst Morgan Housel named names while asking for change. New CEO Meg Whitman isn’t changing the troubled company much, leaving Hewlett-Packard Company (NYSE:HPQ) investors adrift in the rudderless aftermath of the cost-cutting Hurd era. What will it take for investors to grow weary of Hewlett-Packard Company (NYSE:HPQ)’s bumbling strategic advisors?

HP’s board is positively youthful by the standards of the Dow Jones Industrial Average (INDEXDJX:.DJI), where the company is a long-standing member. The average HP director is only 56 years old and has served the board for about three years, putting the average starting point smack in the middle of the Hurd scandal. Age doesn’t automatically translate into wisdom, but it seems odd that the Dow Jones Industrial Average (INDEXDJX:.DJI)’s most derided board also happens to be on the young side. The lack of long-tenured leadership here is partly a result of the post-Hurd overhaul. But the job wasn’t finished when the refreshed board continued to make staggering mistakes.

And now we’re back to a strategy that smacks of Hurd-style cost concerns at a time when a strict focus on innovation and bold ideas seems to be in order. Until that happens, you should expect Apple Inc. (NASDAQ:AAPL) and Google Inc (NASDAQ:GOOG) to keep undermining HP’s decades-long market dominance. The future is increasingly mobile, flexible, and information-based. That’s how Google Inc (NASDAQ:GOOG) and Apple Inc. (NASDAQ:AAPL) can pose such a large threat — and why Apotheker’s software focus may not have been such a bad idea, if he had only paid more attention to the quality of his acquisition targets.

Change starts in the boardroom, folks. I think it’s time to sweep out some more of the remnants of HP’s darkest hour, allowing the company to truly turn a new leaf.

The article Mark Hurd’s Legacy Lives On at Hewlett-Packard originally appeared on is written by Anders Bylund.

Fool contributor Anders Bylund owns shares of Google. The Motley Fool recommends Apple and Google. The Motley Fool owns shares of Apple and Google.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!